BioThera Ok'd to Start China Trial of Biosimilar to JNJ Immune Disease Therapy
BioThera a Guangzhou biotech was approved by China's National Medical Products Administration to start a Phase I trial that compares its Stelara® biosimilar to the original. Johnson &...
View ArticleHuman medicines European public assessment report EPAR Remsima infliximab...
Human medicines European public assessment report EPAR Remsima infliximab Arthritis PsoriaticSpondylitis AnkylosingColitis UlcerativePsoriasisCrohn DiseaseArthritis Rheumatoid Date of authorisation...
View ArticleToll Like Receptor 4 Pipeline Review H2 2019 Published by Global Markets...
Toll Like Receptor 4 Pipeline Review H2 2019SummaryToll Like Receptor 4 hToll or CD284 or TLR4 Tolllike receptor 4 is a protein encoded by the TLR4 gene. This receptor is mostly expressed in placenta...
View ArticleGlutamate Receptor Ionotropic NMDA 2B Pipeline Review H2 2019 Published by...
Glutamate Receptor Ionotropic NMDA 2B Pipeline Review H2 2019SummaryAccording to the recently published report 'Glutamate Receptor Ionotropic NMDA 2B Pipeline Review H2 2019'; Glutamate Receptor...
View ArticleCrohn's Disease Regional Enteritis Pipeline Review H1 2019 Report Updated...
Crohn's Disease Regional Enteritis Pipeline Review H1 2019SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Crohn's Disease Regional Enteritis Pipeline Review...
View ArticleGelesis Secures Over $84 Million in New Capital to Support Commercialization...
Vitruvian Partners leads a $63.4 million equity round complemented by $21.2 million in new nondilutive grant funding and loans to further support commercialization effortsGelesis a biotechnology...
View ArticleFDA Approves Amgens Avsola infliximabaxxq for the Same Indications as Remicade
THOUSAND OAKS Calif.ÂDec. 6 2019ÂPRNewswire &8212;ÂAmgenÂNASDAQAMGN today announced that theÂU.S. Food and Drug AdministrationÂFDA has approved AVSOLA infliximabaxxq for all approved indications of...
View ArticleEngitix and Morphic Enter Research Collaboration to Identify ECMRelated...
Engitix Ltd Engitix a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix ECM platform and Morphic Therapeutic...
View ArticleIntercellular Adhesion Molecule 1 Pipeline Review H2 2019 Published by Global...
Intercellular Adhesion Molecule 1 Pipeline Review H2 2019SummaryIntercellular Adhesion Molecule 1 Major Group Rhinovirus Receptor or CD54 or ICAM1 Intercellular Adhesion Molecule 1 ICAM1 is a protein...
View ArticleEnzo Biochem Reports Fiscal First Quarter Results
Company Announces Plan to Unlock Value for Therapeutics SubsidiaryAnnounces Three LabtoLab RelationshipsAnnounces Appointment of New Chief Financial OfficerEnzo Continues to Take Steps in Creating New...
View ArticleTeams of microbes are at work in our bodies. Here's how to figure out what...
Drexel University An algorithm akin to the annoyingly helpful one that attempts to autocomplete text messages and emails is now being harnessed for a better cause. A group of Drexel University...
View ArticleCrohn's Disease CD Market Review Epidemiology And Market Forecast 2029...
FirstView Market Insight " Crohn's Disease Market Review Epidemiology and Market Forecast 2029" provides in depth understanding of historical and forecasted epidemiology along with the detailed market...
View ArticleUlcerative Colitis UC Market Review Epidemiology And Market Forecast 2029...
FirstView Market Insight " Ulcerative colitis Market Review Epidemiology and Market Forecast 2029" provides in depth understanding of historical and forecasted epidemiology along with the detailed...
View ArticleT Cell Surface Glycoprotein CD3 Epsilon Chain T Cell Surface Antigen T3Leu 4...
T Cell Surface Glycoprotein CD3 Epsilon Chain T Cell Surface Antigen T3Leu 4 Epsilon Chain or CD3E Pipeline Review H1 2019SummaryAccording to the recently published report 'T Cell Surface Glycoprotein...
View ArticleRapid asthma diagnosis with a drop of blood
Asthma is one of the most common respiratory diseases worldwide affecting more than 235 million patients. Dyspnoea shortness of breath and coughing are just a few of the potential symptoms with those...
View Article1999 to 2017 Saw Drop in IBD Hospitalization Rate for Whites
THURSDAY Dec. 12 2019 From 1999 to 2017 the hospitalization rate for Crohn disease and ulcerative colitis decreased among nonHispanic white Medicare beneficiaries aged 65 years but not among...
View ArticleCanadian gastroenterologists issue biosimilar position statement
The Canadian Association of Gastroenterology CAG and Crohns and Colitis Canada announced on 24 October 2019 that they had issued a joint position statement on the use of biosimilars for the treatment...
View ArticleCrohn's Disease CD Market Review Epidemiology And Market Forecast 2029...
FirstView Market Insight " Crohn's Disease Market Review Epidemiology and Market Forecast 2029" provides in depth understanding of historical and forecasted epidemiology along with the detailed market...
View ArticleUlcerative Colitis UC Market Review Epidemiology And Market Forecast 2029...
FirstView Market Insight " Ulcerative colitis Market Review Epidemiology and Market Forecast 2029" provides in depth understanding of historical and forecasted epidemiology along with the detailed...
View Article